Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Comparative Biochemistry and Physiology B
Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities. International Journal of Obesity
Wang W-Y, Liu X, Gao X-Q, Li X, Fang Z-Z
Sales: $26.1 Billion Headcount: 9,000 Revenues: $26,107 (-13%) Net Income: $4,628 (-66%) R&D: $3,734 (-27%) TOP SELLING DRUGS Antiviral product sales for Gilead, which make up the bulk of its revenue and include HIV, chronic hepatitis B (HBV) and chronic hepatitis C (HCV) products, were $23.3 billion compared to $27.7 billion in 2016
Kirkegaard H, Bliddal M, Stvring H, Rasmussen KM, Gunderson EP, Kber L, et al
S suy gim GLP-1 ngi mc i tho ng tup 2 l mt yu t quan trng nh hng n vic qun l bnh
US$ 29.82
US$ 27.42
US$ 24.72
US$ 25.90
US$ 22.57
US$ 28.17
US$ 27.63
US$ 29.92
US$ 21.81
US$ 27.47
